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Abstract
Background: Serotonin N-acetyltransferase (arylalkylamine N-
acetyltransferase, AANAT) catalyzes the first, rate-limiting step in
the biosynthesis of the circadian hormone melatonin (5-methoxy-
N-acetyltryptamine) from serotonin. Our recent discovery that, in
addition to catalyzing the acetyl transfer from acetyl-coenzyme A
(acetyl-CoASH) to serotonin, AANAT is also a robust catalyst for
the alkyl transfer reaction between CoASH and N-bromoacetyl-
tryptamine has not only opened up a new way to develop cell-
permeable AANAT acetyltransferase inhibitors that are valuable
in vivo tools in helping elucidate melatonin’s (patho)physiological
roles, but has also raised a question ^ how does AANAT
accelerate the alkyl transfer reaction? In this study, mechanistic
aspects of the AANAT-catalyzed alkyl transfer reaction were
explored by employing CoASH and a series of N-haloacetyltrypt-
amines that were also evaluated for their AANAT acetyltransfer-
ase inhibitory activities.
Results : Investigation of various N-haloacetyltryptamine ana-
logs showed a similar leaving group effect on the enzymatic and
non-enzymatic reaction rates. Steady-state kinetic analyses dem-
onstrated that AANAT alkyltransferase obeys a sequential,
ternary complex mechanism, with random substrate binding. Rate
versus pH profiles revealed the catalytic importance of an
ionizable group with pKaV7. All those N-haloacetyltryptamines
that serve as substrates of AANAT alkyltransferase are also
potent (low micromolar) in vitro inhibitors against AANAT
acetyltransferase activity. In particular, N-chloroacetyltryptamine
was also shown to be a potent inhibitor of intracellular melatonin
production in a pineal cell culture assay.
Conclusions: This is the first detailed investigation of the
alkyltransferase activity associated with an acetyltransferase. Our
results indicate that AANAT does not accelerate the alkyl transfer
reaction by simple approximation effect as previously proposed
for the similar alkyl transfer reaction catalyzed by other
acyltransferases. This study has general implications for develop-
ing novel inhibitors by taking advantage of the promiscuous
alkyltransferase activity associated with several acyltransfer-
ases. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Arylalkylamine N-acetyltransferase ; Alkyltransferase;
Inhibition; Mechanism
1. Introduction
Serotonin N-acetyltransferase (arylalkylamine N-acetyl-
transferase, AANAT) catalyzes the ¢rst, rate-limiting step
in the biosynthesis of the circadian hormone melatonin (5-
methoxy-N-acetyltryptamine) from serotonin (Fig. 1) [1^
5]. AANAT has received wide attention during past years
for at least two reasons. First, although melatonin has
been claimed to be e¡ective in treating disorders ranging
from insomnia to cancers to Alzheimer’s disease, and in
reversing the aging process, solid scienti¢c foundation is
still lacking for most of these claims, and physiological/
pathophysiological roles played by melatonin are still un-
clear [6^14]. It is conceivable that AANAT, being the rate-
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limiting enzyme in the biosynthesis of melatonin, is a val-
uable target for developing potent, speci¢c, and cell-per-
meable AANAT inhibitors to address the (patho)physio-
logical relevance of melatonin. Second, AANAT belongs
to the GCN5-related N-acetyltransferase superfamily [15]
that also includes the aminoglycoside N-acetyltransferases,
important in antibiotic resistance [16], and some histone
N-acetyltransferases [17], important in chromatin remod-
elling and gene expression regulation. Recent mechanistic
studies suggested that AANAT [18] and other superfamily
members [19^22] obey sequential kinetic mechanisms and
where determined, acetyl-coenzyme A (acetyl-CoASH)
binds prior to the amine substrate.
Based on the sequential ordered Bi Bi kinetic mecha-
nism of AANAT, we recently developed a potent bisub-
strate analog inhibitor (1) (Figs. 2 and 3) [23,24]. How-
ever, due to its charged nature, compound 1 is predicted
not to be cell-permeable [25], thus rendering it unsuitable
for in vivo studies. Thanks to our recent discovery that, in
addition to catalyzing the acetyl transfer from acetyl-
CoASH to serotonin to form N-acetylserotonin, AANAT
is also a robust catalyst for the alkyl transfer reaction
between CoASH and N-bromoacetyl-tryptamine (2) to
form the bisubstrate analog inhibitor 1 (Fig. 2), compound
2 was shown to be a potent AANAT acetyltransferase
inhibitor in vitro and in vivo [24]. This latter inhibition
was manifested by the fact that compound 2 inhibited the
intracellular melatonin production in a pineal cell culture
assay. The AANAT acetyltransferase inhibitory activity of
compound 2 is believed to result from AANAT-catalyzed
formation of the bisubstrate analog inhibitor 1 from
CoASH and 2, since compound 2 was clearly demon-
strated not to be an a⁄nity label of AANAT [24]. These
previous studies have clearly brought about two issues of
immediate importance, i.e. (i) how AANAT accelerates the
alkyl transfer reaction described above, and (ii) how to
exploit AANAT alkyltransferase activity to develop cell-
permeable AANAT acetyltransferase inhibitors that are
Fig. 1. AANAT-catalyzed acetyltransferase reaction.
Fig. 2. Alkyl transfer reaction between CoASH and N-bromoacetyltryptamine (2).
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superior to our lead compound 2, since conceivably high
intrinsic reactivity of compound 2 toward nucleophilic
species may limit its utility in whole animal studies.
Two acetyltransferases have been previously reported to
be able to catalyze the similar alkyl transfer reaction de-
scribed above for AANAT [26^28]. These include carnitine
acetyltransferase and gentamicin acetyltransferase I. How-
ever, it has remained unclear how these acyltransferases
accelerate the secondary alkyl transfer reaction. In the
case of AANAT, our previous studies suggested that the
acetyltransferase and the alkyltransferase activities of AA-
NAT are catalyzed at functionally distinct sites [24]. As
such, di¡erent catalytic mechanisms are likely employed
by these two transferase activities. In the current study,
mechanistic aspects of the AANAT-catalyzed alkyl trans-
fer reaction were explored by employing CoASH and a
series of N-haloacetyltryptamines that were also evaluated
for their AANAT acetyltransferase inhibitory activities.
We have shown that AANAT alkyltransferase obeys a
sequential, ternary complex mechanism, with random sub-
strate binding. Our results also indicated that AANAT
does not accelerate the alkyl transfer reaction by simple
approximation e¡ect as previously proposed for the sim-
ilar alkyl transfer reaction catalyzed by other acyltransfer-
ases. We have also found that N-chloroacetyltryptamine
(4, Fig. 3) was a potent in vitro and in vivo AANAT
acetyltransferase inhibitor.
2. Results and discussion
2.1. Role of the leaving group
Among the ¢rst AANAT alkyltransferase reaction
mechanistic features we planned to analyze was the role
of the leaving group in the reaction. To address this issue,
in addition to N-bromoacetyltryptamine (2), we have pre-
pared N-£uoroacetyltryptamine (3), N-chloroacetyltrypt-
amine (4), and N-iodoacetyltryptamine (5) using standard
amide-bond-forming reactions between tryptamine and the
corresponding halo-acetic acid (Fig. 3). These compounds
were reacted with CoASH in the presence and absence of
AANAT at pH 6.8. The second-order rate constants for
the uncatalyzed reaction are shown in Table 1. As ex-
pected [29^32] (see below), the rate for iodide displacement
involving 5 was similar (about two-fold faster) to that of
the bromide displacement reaction with 2, which in turn
was 50-fold faster than the chloride reaction involving 4.
The £uoride displacement reaction employing 3 was un-
detectable. The AANAT-catalyzed alkyltransferase reac-
tions showed similar overall trends in rate to the corre-
sponding non-enzymatic reactions, as displayed in Table 1,
but several di¡erences were observed. The AANAT-cata-
lyzed iodide displacement reaction involving 5 was slightly
slower (two-fold) compared to the enzyme-catalyzed bro-
mide displacement reaction. Most notably, the chloride
Fig. 3. Structures of compounds employed in this study.
Table 1
Kinetic parameters for N-haloacetyltryptamines 2^6 as non-enzymatic and AANAT substrates for alkyl transfer to CoASH
N-Haloacetyltryptamine Non-enzymatic (k)a Km (mM) kcat (min31) kcat/Km (mM31 min31) kcat/kbuncat
2 4.2U1032 3.6 þ 0.6 160 þ 11.5 45 3.3U104
3 6 1036 6 0.0013
4 8.2U1034 1.7 þ 0.4 22 þ 1.7 13 2.2U105
5 7.4U1032 3.0 þ 0.7 83.7 þ 10.6 27.9 9.4U103
6 0.3 þ 0.07 14 þ 1.4 46.8
aSecond-order rate constant (M31 s31).
bkuncat, pseudo-¢rst-order rate constant at ¢xed N-haloacetyltryptamine (2 mM).
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displacement reaction with substrate 4 was only 7.4-fold
lower in kcat and about 3.5-fold smaller in kcat/Km com-
pared to the AANAT-catalyzed alkyltransferase reaction
involving the bromide substrate 2. The enzyme-catalyzed
displacement of £uoride in compound 3 was undetectable,
similar to the non-enzymatic reaction.
The relative rate acceleration (kcat/kuncat) for alkyl trans-
fer involving the chloride substrate 4 by AANAT is
2.2U105, which is almost an order of magnitude greater
than that corresponding to reaction of the bromide sub-
strate 2 (Table 1). In principle several possibilities could
account for the greater relative enzymatic reactivity of
chloride 4 compared to bromide 2. For non-enzymatic
SN2 reactions, a body of work has demonstrated that
the nature of the leaving group can signi¢cantly in£uence
the rate [29^32]. The order of reactivity for halide leaving
groups in these reactions is typically IvBrsClEF [29^
32]. However, for enzyme-catalyzed nucleophilic displace-
ment reactions [33^35], the relative rate dependence on the
leaving group may be di¡erent from the non-enzymatic
cases for several reasons. First, the chemical step may
not be rate-determining for the overall kcat. For example,
product release may be much slower than the chemical
step and rate-determining for the overall reaction [36].
This could mask rate reductions due to substitutions
with poorer leaving groups that would only impact the
chemical step. Second, di¡erent leaving groups may bind
speci¢cally with active site residues. Such binding interac-
tions could be a¡ected by subtle changes in size and shape
of the leaving groups, which may in turn in£uence the
e⁄ciency of catalysis. In general it is di⁄cult to carry
out a broad assessment of the e¡ects on rate of varying
the leaving group in enzyme-catalyzed nucleophilic dis-
placement reactions because of geometric constraints. A
homologous halide series in the AANAT case studied
here, however, o¡ers a more hopeful system than for ex-
ample the pyrophosphate leaving group in prenyltransfer-
ases because subtle alterations of the pyrophosphate func-
tion are less apparent [33^35]. Third, the enzyme may alter
the nature of the transition state by neutralizing charge
build-up on the leaving group with a general acid group,
or by in£uencing the reaction to proceed via a covalent
enzyme intermediate over two chemical steps. Either of
these e¡ects could lessen the apparent importance of the
leaving group on the overall reaction [37].
In our opinion, the best explanation for the rate e¡ects
with AANAT is that the chemical step is fully rate-deter-
mining for AANAT-catalyzed alkyl transfer reaction with
chloride substrate 4, whereas in the case with bromide
substrate 2, the chemical step is only partially rate-deter-
mining for the overall kcat. Support for this assertion
comes from studies on the alkyltransferase reaction cata-
lyzed by [Y168F]-AANAT. Previous work by Hickman et
al. showed that this tyrosine residue is important for the
acetyltransferase reaction (the mutant showed about a 30-
fold kcat reduction with tryptamine as substrate) and its
phenol hydroxyl is in hydrogen bonding distance to the
sulfur atom of the bisubstrate analog 1 in an X-ray struc-
ture [38]. The same Y168F mutant was generated and used
to investigate the alkyltransferase reaction. Interestingly,
this Y168F mutant showed a kcat (0.55 min31) which
was 290-fold reduced in its catalysis of the alkyltransferase
reaction with the bromide substrate 2. In contrast, the
reduction was 2200-fold with the chloride substrate 4
(kcat = 0.010 min31). The reduction was 70-fold with
Y168F and the iodide substrate 5 (kcat = 1.2 min31).
These studies also suggested that the chemical step is
rate-determining for [Y168F]-AANAT-catalyzed alkyl
transfer reaction with all three substrates, i.e. iodide 5,
bromide 2, and chloride 4. This is evident from the fact
that the ratio of apparent kcat values for the [Y168F]-AA-
NAT-catalyzed reactions (5 :2 :4 = 120:55:1) is essentially
identical to that for the non-enzymatic reactions
(5 :2 :4 = 90:51:1). This comparison also suggests that the
extent of leaving group departure in the chemical step
transition state is likely to be similar for AANAT-cata-
lyzed and non-enzyme-catalyzed alkyl transfer reactions.
From modelling studies it seems implausible that Tyr-
168 can interact with the leaving halide atoms. Further-
more, even if Tyr-168 were stabilizing the departing hal-
ides, it would seem unlikely that it would preferentially
stabilize chloride over bromide. For these reasons, we be-
lieve the simplest rationale for the chloride and bromide
alkyltransferase rates with wild-type AANAT is that the
chemical step is only partially rate-limiting with 2, but
fully rate-limiting with 4. It is interesting that the Tyr-
168 side chain is important for enhancing the AANAT
alkyltransferase reaction, and we rationalize this role as
due to a hydrogen-bonding interaction between CoASH
and the phenol hydroxyl, orienting the CoASH substrate
for attack.
2.2. Steady-state kinetic analysis
By employing CoASH and N-chloroacetyltryptamine
(4) as substrates for the AANAT-catalyzed alkyl transfer
reaction, steady-state kinetic analysis and rate versus pH
experiments (see below) were performed. The choice of the
chloride substrate 4 for these experiments was based on
studies described above. Among the three substrates (2, 4,
and 5), the chloride substrate 4 displayed the greatest en-
hancement in the AANAT-catalyzed versus uncatalyzed
rate and therefore should provide a greater signal-to-noise
ratio in a detailed kinetic analysis. Furthermore, since the
chemical step (as opposed to product release) is rate-de-
termining for the AANAT-catalyzed reaction with this
substrate, use of the chloride compound 4 in kinetic stud-
ies is likely to lead to simpler interpretations.
While the AANAT-catalyzed acetyltransferase reaction
proceeds via a sequential mechanism [18], it was formally
possible that a covalent enzyme intermediate for the AA-
NAT alkyltransferase reaction could occur, which would
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likely follow a ping-pong kinetic mechanism. To distin-
guish between these possibilities, a two-substrate kinetic
analysis was performed [39]. In this experiment, a clear
intersecting line pattern as opposed to a parallel line pat-
tern was observed (Fig. 4). This suggests that the AA-
NAT-catalyzed alkyltransferase reaction proceeds via a
sequential mechanism, and a direct attack of CoASH on
4 is expected.
The next question concerning the kinetic mechanism
was whether substrate binding of CoASH and 4 follows
a random pathway or whether ordered binding of one
substrate prior to the other occurs. AANAT-catalyzed
acetyltransferase activity shows an ordered Bi Bi kinetic
mechanism in which acetyl-CoASH binding precedes sero-
tonin (or tryptamine) binding [18]. One criterion for the
ordered Bi Bi classi¢cation was the ¢nding that the bisub-
strate analog 1 was a competitive inhibitor versus acetyl-
CoASH and a non-competitive inhibitor versus tryptamine
[23,24]. In the current work, we carried out analogous
studies with the bisubstrate analog inhibitor 7 (Fig. 3),
also a close analog of the direct product (1) for the reac-
tion between CoASH and the chloride substrate 4. Com-
pared to 1, compound 7 shows slightly increased (2^4-
fold) potency with regard to inhibiting AANAT acetyl-
transferase and alkyltransferase activity [24]. More impor-
tant for this work, it is well separated from 1 (7 shows
about 2 min increased retention time) under the high pres-
sure liquid chromatography (HPLC) assay conditions used
here and does not interfere with quantitative analysis of
the alkyltransferase activity.
When the inhibition pattern of analog 7 for the AA-
NAT-catalyzed alkyltransferase reaction was analyzed, 7
was found to be a linear competitive inhibitor versus both
CoASH and substrate 4 (Fig. 5). The measured Kis ex-
trapolated to zero concentration of both substrates was
V700 nM, which should be equal to the Kd for 7 with
respect to the alkyltransferase active site. This pattern of
inhibition di¡ers from the pattern observed with bisub-
strate analog inhibition of the AANAT acetyltransferase
reaction and suggests that substrates CoASH and 4 bind
to AANAT randomly for the alkyltransferase reaction.
The ¢nding of the di¡erence in the order of substrate
binding for the AANAT acetyltransferase and alkyltrans-
ferase reactions is compatible with the possibility that the
alkyltransferase reaction takes place in a separate and con-
formationally altered active site on AANAT compared to
the acetyltransferase reaction [24]. A comparison of the
approximate Kd values for the acetyltransferase site (22
nM) [24] versus the alkyltransferase site (700 nM) by the
same molecule 7 is also consistent with this possibility.
How these conformationally altered active sites arise is
unknown but they may represent di¡erences within an
asymmetric homodimer of the AANAT protein as has
been discussed previously [24].
Fig. 4. Two-substrate kinetic analysis of AANAT alkyltransferase activ-
ity. E/V versus 1/[CoASH] at three ¢xed N-chloroacetyltryptamine (4)
concentrations (0.5, 1, and 2 mM). Alkyltransferase assays and data ¢t-
ting were performed as described in Section 4. The catalytic parameters
are: kcat, 18 þ 2 min31 ; Km (CoASH), 0.11 þ 0.04 mM; Km (4),
0.87 þ 0.19 mM; Kia (CoASH), 0.13 þ 0.06 mM.
Fig. 5. Bisubstrate analog 7 inhibition of AANAT alkyltransferase activ-
ity. (A) E/V versus 1/[CoASH] at ¢xed N-chloroacetyltryptamine (4)
concentration (4 mM) and varying concentrations of bisubstrate analog
7 (0, 12, and 25 WM). The catalytic parameters are: kcat, 12 þ 0.2
min31 ; Km (CoASH), 0.088 þ 0.008 mM; Kis (7), 2.1 þ 0.2 WM. (B) E/V
versus 1/[4] at ¢xed CoASH (2 mM) and varying concentrations of 7 (0,
12, and 24 WM). The catalytic parameters are: kcat, 16 þ 1 min31 ; Km
(4), 1.3 þ 0.1 mM; Kis (7), 17 þ 3 WM. Alkyltransferase assays and data
¢tting were performed as described in Section 4.
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2.3. E¡ects of pH changes on the alkyltransferase activity
It was unclear if AANAT’s alkyl transfer rate enhance-
ment is due solely to a simple approximation e¡ect, bring-
ing the two substrates close together, or if enzyme active
site residues are directly facilitating the reactions with hy-
drogen bonding or general base catalysis. In the non-en-
zymatic reaction, the thiolate anion of CoASH would be
expected to be the active nucleophilic species and this alkyl
transfer reaction should be accelerated by base catalysis.
Indeed, pH titration of the non-enzymatic reaction rate
shows that log(k) versus pH is linear with a slope near 1
(+0.91 þ 0.07) in the pH range 6^8.2 (Fig. 6). The pKa of
the CoASH thiol has been reported to be 9.6 [40] and
therefore one would expect that the rate of the non-enzy-
matic reaction would not plateau until approaching pH
9.6.
In contrast, the pH^rate pro¢le of the AANAT-cata-
lyzed alkyltransferase reaction (log(kcat) versus pH) shows
an ‘acidic limb’ which plateaus around pH 8 (Fig. 7A).
Fitting of these data to a model with a single titrating
functionality provides evidence for an ionizable group
with pKa = 7.1 in which the deprotonated form is the ac-
tive species. Since plots of log(kcat) versus pH should re-
£ect the pKa values of important catalytic groups in the
bound complex of enzyme plus substrate(s) [41], this ion-
izable group is likely to be either the CoASH thiol or an
acid^base functionality on an enzyme residue. Due to sig-
nal-to-noise limitations, it was not possible to carry out
reliable pH^rate measurements on [Y168F]-AANAT, and
the contributions of this residue could not be assessed.
Although the pKa from the wild-type AANAT reaction
is much lower than that of the CoASH thiol, it is well
known that protein active sites can alter the pKa values
of ionizable groups on ligands compared to their values in
free solution. These pKa changes can result from hydrogen
bonding, dielectric constant changes, or electrostatic ef-
fects. Interestingly, the log(kcat/Km-CoASH) versus pH
plot, which should re£ect acid^base groups on the un-
bound enzyme or free substrates [41], shows a similar pro-
¢le with a single ionizable group with pKa = 6.4, near the
value of 7.1 for the kcat pro¢le (Fig. 7B). In this case, this
plot presumably represents a pKa value of a group on an
enzyme residue in the unbound form, since the CoASH
thiol pKa is 9.6 in free solution [40] and N-chloroacetyl-
tryptamine lacks ionizable groups. It is unlikely to be re-
Fig. 6. Non-enzymatic rate of alkyl transfer reaction between CoASH
and 4 as a function of pH. These reactions were carried out with ¢xed
CoASH (2 mM) and 4 (2 mM) concentrations as described in Section 4.
It has been shown previously that the reaction is second order with re-
spect to both substrates in this concentration range [24]. The vertical
axis represents the log(k) where k is the second-order rate constant
(M31 s31). Data were ¢tted using a least squares linear model
(slope = +0.91 þ 0.07)
Fig. 7. AANAT-catalyzed alkyltransferase activity as a function of pH.
(A) log(kcat) versus pH. (B) log(kcat/Km (CoASH)) versus pH. Each of
these plots was ¢t to re£ect a single ionizable group which is active
only in the deprotonated form with pKa = 7.1 for kcat and pKa = 6.4 for
kcat/Km. See Section 4 for details.
Table 2
Steady-state kinetic parameters for N-haloacetyltryptamines (2^6) as in-
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lated to the 3P-phosphate of CoASH which is not critical
for CoASH binding [24].
There are two possible interpretations for the pH^rate
pro¢le results of the AANAT-catalyzed alkyltransferase
reaction. Firstly, the key catalytic ionizable group in
both the free and bound complex is the same and therefore
corresponds to an enzymatic residue side chain. In this
scenario, it is reasonably predicted to be a general base
catalyst which assists in the proton removal of the CoASH
thiol proton, activating it for nucleophilic attack. This
proton transfer could occur either directly or through in-
tervening water molecules [38]. Of note, there appears to
be an ionizable group, as yet unidenti¢ed, with a similar
pKa that is important for AANAT acetyltransferase catal-
ysis, possibly as a general base [42]. Another possibility,
although somewhat more complicated, is that the ioniz-
able group detected in the free enzyme is di¡erent from
the group with a similar pKa in the bound complex. In this
scenario, the group in the bound complex might then be
the CoASH thiol in which its pKa falls 2.5 units in the
environment of the enzyme active site. However, in either
case, these data suggest that AANAT uses chemical
groups to directly enhance the SN2 reaction. In the ¢rst
case this occurs by assisting proton transfer in the transi-
tion state and in the second case by increasing the propor-
tion of the powerful nucleophile thiolate anion at neutral
pH.
2.4. Acetyltransferase inhibition
Our recent discoveries that, in addition to catalyzing the
acetyl transfer from acetyl-CoASH to serotonin, AANAT
is also a robust catalyst for the alkyl transfer reaction
between CoASH and N-bromoacetyltryptamine (2), as
well as that compound 2 was shown to be a potent AA-
NAT acetyltransferase inhibitor in vitro and in vivo [24]
have placed AANAT alkyltransferase activity in a central
position for developing cell-permeable AANAT acetyl-
transferase inhibitors by pharmacologically exploiting the
alkyltransferase reaction. In this regard, it was worthwhile
to attempt to correlate the acetyltransferase inhibitory po-
tency of compounds 2^5 with respect to their alkyltrans-
ferase substrate activity in vitro. As can be seen in Table 2,
the acetyltransferase inhibitory potency correlated fairly
well with the alkyltransferase substrate activity. As ex-
pected, chloride 4 (IC50 = 5.2 WM) was less potent than
bromide 2 (IC50 = 0.5 WM) in blocking AANAT acetyl-
transferase activity in vitro. Because of a short incubation
time (4 min), this in vitro acetyltransferase inhibition
screening assay is somewhat biased in favor of a halide
compound which can undergo more rapid alkyltransferase
reaction. A more biologically relevant assay in which mel-
atonin production is measured in pineal cells can also be
employed. Indeed, in the pinealocyte melatonin produc-
tion assay which takes place over a much longer time
period (6 h), the IC50 values for 4 (V500 nM, see Table
3) and 2 (V200^400 nM, see [24]) were fairly similar.
Other parameters which impact bioavailability such as
cell entry, protein binding, and metabolic stability will
also a¡ect the comparison in cell culture assays as well
as animal studies [43]. Because of its reduced spontaneous
rate of reacting with nucleophiles compared to bromide 2,
chloride 4 can plausibly be expected to have more favor-
able pharmacokinetic behavior compared to 2.
To further explore the design of acetyltransferase inhib-
itors, we investigated compound 6 (Fig. 3) as an alkyl-
transferase substrate (Table 1) and acetyltransferase inhib-
itor (Table 2). It was reported previously that bromo-
substituted bisubstrate analog 7 is a somewhat more po-
tent acetyltransferase inhibitor (ca. two-fold) compared to
the parent bisubstrate analog 1 [24]. Moreover, it was
recently shown that 5-bromotryptamine is a ¢ve-fold
more e⁄cient substrate for AANAT acetyltransferase pro-
cessing (kcat = 25 s31, Km = 0.03 mM; unpublished data
from the Cole laboratory), compared to serotonin or
tryptamine. It was of interest to determine whether 5-bro-
mo substitution would lead to enhanced AANAT alkyl-
transferase processing of 6. Indeed, 6 was a more e⁄cient
alkyltransferase substrate than 4 (Table 1) and the e¡ect
was solely a Km rather than a kcat e¡ect. This suggests that
the acetyltransferase binding site for 5-bromo-tryptamine
shares structural homology with the alkyltransferase bind-
ing site for 5-bromo-N-chloroacetyltryptamine. Despite
this, 6 did not show enhanced acetyltransferase inhibition
properties compared to 4 (Table 2) in the in vitro assay.
The IC50 values were indistinguishable within the standard
error of the measurement. While the reasons for this lack
of enhanced potency for 6 are not fully known, it suggests
that the kcat of the alkyltransferase reaction is more im-
portant than the Km as a predictor for potent inhibition in
the in vitro acetyltransferase assay. Due to the cross-reac-
tivity with melatonin, compound 6 could not properly be
assessed for the blockade of intracellular melatonin pro-
duction in the pineal cell culture assay.
3. Signi¢cance
Although alkylation catalysis has been documented for
Table 3
Inhibition of melatonin production in pinealocytes by N-chloroacetyl-
tryptamine (4)
Treatment Melatonin (pmol/105 cells)
Background 0.60 þ 0.03
4 (85 WM) 0.12 þ 0.05
NE (10 WM)a 15.37 þ 0.41
NE (10 WM)+4 (85 WM) 3.39 þ 0.25
NE (10 WM)+4 (8.5 WM) 3.56 þ 0.61
NE (10 WM)+4 (0.85 WM) 6.07 þ 0.73
aNE = norepinephrine. N = 3. IC50V0.5 WM. See [24] for experimental
details.
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several acyltransferases, including AANAT, it has re-
mained unclear how these acyltransferases accelerate the
secondary (promiscuous) alkyl transfer reaction. In the
current study, mechanistic aspects of AANAT alkyltrans-
ferase activity were examined by employing CoASH and a
series of N-haloacetyltryptamines. We have shown that the
leaving group ability is an important determinant of AA-
NAT-catalyzed alkylation rate as it is for the non-enzy-
matic rate. Steady-state kinetic analyses demonstrated that
AANAT alkyltransferase obeys a sequential, ternary com-
plex mechanism, with random substrate binding. Rate ver-
sus pH pro¢les suggested that general base catalysis or the
lowering of CoASH thiol pKa is important for AANAT
alkyltransferase reaction. These mechanistic studies should
constitute an important contribution to understanding en-
zyme promiscuity. We have also shown that the in vitro
AANAT acetyltransferase inhibitory potency of N-haloac-
etyltryptamines correlated well with their alkyltransferase
substrate activities. In particular, N-chloroacetyltrypt-
amine (4) was also shown to be a potent in vivo AANAT
acetyltransferase inhibitor, as manifested by its potent in-
hibition of intracellular melatonin production in a pineal
cell culture assay. Due to its lower spontaneous reactivity
toward nucleophiles compared to 2, compound 4 is ex-
pected to have more favorable pharmacokinetic behavior
and should ¢nd applications in in vivo circadian research.
This study should have general implications for developing
novel inhibitors by taking advantage of the promiscuous
alkyltransferase activity associated with several acyltrans-
ferases.
4. Materials and methods
4.1. General
5-Bromotryptamine hydrochloride was purchased from Bio-
synth Technologies (Skokie, IL, USA). CoASH, 2-(N-morpholi-
no)ethanesulfonic acid (MES), 3-(N-morpholino)propanesulfonic
acid (MOPS), N-(2-hydroxyethyl)piperazine-NP-(3-propanesul-
fonic acid) (EPPS), cysteine, 5,5P-dithiobis-(2-nitrobenzoic acid)
(DTNB), and assay-grade tryptamine hydrochloride were pur-
chased from Sigma. Acetyl-CoASH was purchased from Pharma-
cia Biotech. Sodium phosphate, guanidinium hydrochloride, and
EDTA were purchased from Fisher Scienti¢c. All other reagents
were purchased from Aldrich. All commercially available re-
agents were used as purchased without further puri¢cation. Prep-
arations of N-bromoacetyltryptamine (2) and bisubstrate analog
inhibitors 1 and 7 have been described previously [23,24]. 1H and
13C nuclear magnetic resonance (NMR) spectra were obtained
with a Bruker AMX 300 spectrometer (300 and 75.5 MHz, re-
spectively), and chemical shift values (N) were expressed as ppm
relative to tetramethylsilane. Elemental analyses were performed
by Robertson Microlit Laboratories (Madison, NJ, USA), and
the values found were within þ 0.4% of the theoretical values.
Silica gel (Merck, 63^200 mesh, 60 Aî ) was used for the £ash
column chromatography. Analytical thin layer chromatography
(TLC) was performed on Sigma-Aldrich silica gel 60 F 254 TLC
plates (thickness: 200 Wm). The preparation of recombinant sheep
glutathione S-transferase (GST)^AANAT (V90% pure) which
was expressed in Escherichia coli has been described previously,
and it has been shown that nearly identical acetyltransferase ki-
netic behavior was observed for GST^AANAT and GST-free
AANAT [18]. GST^AANAT and GST-free AANAT were also
shown to have essentially identical alkyltransferase kinetic behav-
ior with the bromide compound 2 [24]. In particular the GST
domain is unable to catalyze the AANAT alkyltransferase reac-
tions [24]. Therefore, GST^AANAT was used for all the studies
described in this manuscript.
4.2. Synthesis of N-£uoroacetyltryptamine (3)
To a well-stirred, ice-cooled two-phase solution of tryptamine
(3.2 g, 20 mmol) and sodium £uoroacetate (2.2 g, 22 mmol) in a
mixture of 0.5 M HCl (44 ml), methylene chloride (200 ml), and
water (15 ml) was added in small portions 1-(3-dimethylamino-
propyl)-3-ethylcarbodiimide hydrochloride (EDCWHCl; 4.22 g, 22
mmol). After the addition was complete, the reaction mixture was
stirred vigorously at room temperature overnight. The organic
layer was isolated, washed with water, and concentrated. The
residue was dissolved in freshly degassed (45 min with N2)
MeOH (125 ml), and was treated with a solution of L-cysteine
(665 mg, 5.5 mmol) in 1.0 M triethyl-ammonium bicarbonate
bu¡er (pH 8.5, 125 ml). After being stirred at room temperature
overnight, the solution was concentrated, and extracted with
methylene chloride. The organic extract was washed with water,
0.5 M HCl, 1.0 M NaHCO3, brine, and dried over anhydrous
Na2SO4. Removal of solvents gave a white solid which was crys-
tallized in methylene chloride/hexane, a¡ording 694 mg (16%) of
3 as white crystals. 1H NMR (CDCl3) N 8.09 (bs, 1H), 7.62 (d,
J = 7.8 Hz, 1H), 7.39 (d, J = 8.0 Hz, 1H), 7.23 (t, J = 7.1 Hz, 1H),
7.14 (t, J = 7.1 Hz, 1H), 7.06 (s, 1H), 6.4 (bs, 1H), 4.77 (d, J = 47.1
Hz, 2H), 3.69 (q, J = 6.5 Hz, 2H), 3.03 (t, J = 6.8 Hz, 2H); 13C
NMR (CDCl3) N 167.6, 136.4, 127.1, 122.2, 122.0, 119.4, 118.5,
112.3, 111.3, 81.1, 79.3, 39.0, 25.2. Anal. calcd. for C12H13N2OF:
C, 65.44; H, 5.95; N, 12.72. Found: C, 65.29; H, 5.90; N, 12.73.
4.3. Synthesis of N-chloroacetyltryptamine (4)
To a stirred, ice-cooled suspension of tryptamine (160 mg, 1.0
mmol) and chloroacetic acid (104 mg, 1.1 mmol) in methylene
chloride (15 ml) was added in small portions EDCWHCl (211 mg,
1.1 mmol). After the addition was complete, the reaction mixture
was stirred at room temperature overnight. The organic layer was
isolated, and the aqueous layer was extracted once with methyl-
ene chloride. The combined organic was washed with 0.5 M HCl,
1.0 M NaHCO3, water, brine, and dried over anhydrous Na2SO4.
Removal of solvents gave a white solid which was crystallized in
methylene chloride/hexane, a¡ording 211.4 mg (89%) of 4 as
white crystals. 1H NMR (CDCl3) N 8.09 (bs, 1H), 7.62 (d,
J = 7.8 Hz, 1H), 7.39 (d, J = 8.1 Hz, 1H), 7.23 (t, J = 7.2 Hz,
1H), 7.15 (t, J = 7.8 Hz, 1H), 7.07 (s, 1H), 6.67 (bs, 1H), 4.02
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(s, 2H), 3.65 (q, J = 6.5 Hz, 2H), 3.03 (t, J = 6.7 Hz, 2H); 13C
NMR (CDCl3) N 165.8, 136.4, 127.1, 122.3, 122.0, 119.6, 118.6,
112.5, 111.3, 42.7, 40.0, 25.1. Anal. calcd. for C12H13N2ClO: C,
60.89; H, 5.54; N, 11.83. Found: C, 60.80; H, 5.45; N, 11.82.
4.4. Synthesis of N-iodoacetyltryptamine (5)
In the same manner as compound 4, tryptamine (160 mg, 1.0
mmol) was coupled with iodoacetic acid (204.5 mg, 1.1 mmol) in
the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
methiodide (327 mg, 1.1 mmol), a¡ording 95.7 mg (29%) of 5
as a white powder after £ash silica gel chromatography
(EtOAc/hexane = 1/3C1/1). 1H NMR (DMSO-d6) N 10.81 (bs,
1H), 8.33 (bs, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.33 (d, J = 8.1 Hz,
1H), 7.15 (s, 1H), 7.06 (t, J = 7.8 Hz, 1H), 6.97(t, J = 7.8 Hz, 1H),
3.63 (s, 2H), 3.27^3.40 (m, 2H), 2.81 (t, J = 7.2 Hz, 2H). 13C
NMR (DMSO-d6) N 167.5, 136.2, 127.1, 122.8, 120.9, 118.3,
118.2, 111.5, 111.4, 40.0, 24.8, 12.1. Anal. calcd. for C12H13N2OI:
C, 43.92; H, 3.99; N, 8.54. Found: C, 44.00; H, 3.98; N, 8.47.
4.5. Synthesis of 5-bromo-N-chloroacetyltryptamine (6)
In the same manner as compound 4, starting from 5-bromo-
tryptamine hydrochloride (82.7 mg, 0.3 mmol), chloroacetic acid
(31.2 mg, 0.33 mmol), and EDCWHCl (63.3 mg, 0.33 mmol) in the
presence of Et3N (47.4 Wl, 0.34 mmol), 70 mg (74%) of 6 was
obtained as white crystals after crystallization from methylene
chloride/hexane. 1H NMR (DMSO-d6) N 11.04 (bs, 1H), 8.29
(bs, 1H), 7.71 (s, 1H), 7.30 (d, J = 8.6 Hz, 1H), 7.21 (s, 1H),
7.16 (d, J = 8.6 Hz, 1H), 4.04 (s, 2H), 3.27^3.38 (m, 2H), 2.80
(t, J = 7.5 Hz, 2H); 13C NMR (DMSO-d6) N 165.8, 134.9, 129.1,
124.5, 123.4, 120.6, 113.4, 111.5, 111.0, 42.7, 39.8, 24.6. Anal.
calcd. for C12H12N2BrClO: C, 45.67; H, 3.83; N, 8.88. Found:
C, 45.67; H, 3.67; N, 8.90.
4.6. AANAT alkyltransferase assays of N-haloacetyltryptamines
A HPLC assay was performed to measure the rate of product
(bisubstrate analog 1 or 7) formation in the presence and absence
of AANAT, as described previously [24]. Brie£y, the assay reac-
tions (pH 6.8) were quenched with a 6 M aqueous guanidinium
hydrochloride solution (pH 3.0), and the whole mixtures were
subjected to analytical reverse-phase HPLC analysis on a C-18
column (100 Aî , 0.46U25 cm) to identify and quantify the reac-
tion product (bisubstrate analog 1 or 7) by automated integration
using authentic synthetic materials as standards. Chromatograms
were obtained by eluting the column with a gradient of 50 mM
aqueous potassium phosphate bu¡er (pH 4.5) (mobile phase A)
and MeOH (mobile phase B) (0^3 min, 0% B; 3^15 min, linear
increase to 65% B; 15^20 min, linear increase to 100% B; 20^26
min, linear decrease to 0% B) (1 ml/min), and UV monitoring at
260 and 279 nm. Under these conditions, the following retention
times were obtained: CoASH, 11 min; 1, 15 min; 2, 19 min; 3, 18
min; 4, 19 min; 5, 21 min; 6, 21 min; 7, 17 min. The kinetic
behavior of bromide 2 with AANAT has been characterized pre-
viously, and shows second-order kinetics in the 2 mM concen-
tration range in the absence of enzyme [24]. Stock solutions of 3^
6 were prepared in a mixture of propylene glycol (PG) and dou-
bly distilled water (33^56% of PG (v/v)), and the ¢nal PG con-
centration in an assay reaction was maintained at 9 10% (v/v).
All assay reactions were performed at 30‡C, and were initiated
with the addition of potential N-haloacetyl-tryptamine substrates.
Typical progress curves were obtained with the use of 2 mM of
CoASH and 2 mM of N-haloacetyltryptamines in the presence
and absence of 0.5^50 WM of AANAT. Linearity was obtained
for both enzymatic and non-enzymatic reactions. Non-enzymatic
reaction rates serve as backgrounds and were subtracted in all
cases. For analogs whose enzymatic reaction was detectable, their
kcat and Kmapparent values were measured. For this purpose, N-
haloacetyltryptamine substrate concentrations ranging from 0.5
to 8.0 mM (but 0.5^4.0 mM for 5, and 0.05^1.0 mM for 6 due
to low solubility) were employed in the presence of ¢xed and
near-saturating CoASH (2 mM). 0.5^1.0 WM of AANAT were
employed, and the assay reactions were run for 2 min at 30‡C.
Rate measurements were made under initial conditions, i.e. limit-
ing substrate turnover was maintained at 9 10%. All measure-
ments were made in duplicate and data agreed within 20% in
each duplicate run. Enzyme activity was linear with AANAT
concentration. Kinetic parameters (kcat and Kmapparent) were cal-
culated by ¢tting the data into the Michaelis^Menten equation
using a non-linear least squares approach with the computer pro-
gram Kaleidagraph1 (Reading, PA, USA), and the values are
recorded as mean þ S.E.M. in Table 1.
4.7. [Y168F]-AANAT mutant studies
The [Y168F]-AANAT DNA (independently prepared by Hick-
man et al. [38]) was obtained using the QuikChange Kit (Strata-
gene1) and the mutation con¢rmed by DNA sequencing of the
entire open reading frame. The protein was expressed and puri-
¢ed as the GST fusion construct as described previously [18].
Kinetic assays were carried out as described above for the wild-
type AANAT. The apparent kcat values were determined at sat-
urating concentrations (2 mM, s 3Km) of each substrate (dem-
onstrated for reaction with 2 and CoASH) and are shown in the
text. Precise Km values were di⁄cult to measure because of sig-
nal-to-noise limitations but were 6 0.7 mM for 2 and CoASH.
4.8. Two-substrate kinetic studies
CoASH and N-chloroacetyltryptamine (4) were employed in
the two-substrate kinetic analysis. The kcat and Km measurements
were made for CoASH (concentration range of 0.1^2.0 mM) at
three di¡erent ¢xed concentrations (0.5, 1.0, and 2.0 mM) of
substrate 4. Alkyltransferase assays were performed as described
above and in [24]. A concentration of 1.0 WM of AANAT was
employed. Data were ¢tted into the sequential (ternary complex)
mechanism equation (Eq. 1) using a non-linear least squares ap-
proach with the computer program KinetAsyst II1 (IntelliKi-
netics, State College, PA, USA) based on the Cleland algorithms
[44]. Kinetic parameters are recorded as mean þ S.E.M. in Fig. 4.
Ka = Km of CoASH, Kia = dissociation constant for CoASH to
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free enzyme, Kb = Km of N-chloroacetyltryptamine (4). Fitting to
a ping-pong mechanism gave a larger sum of squares of the
residuals and larger S.E.M. values:
V  V mAB=K iaKb  KaB KbA AB 1
4.9. Product inhibition studies
Bisubstrate analog 7 was employed as a product inhibitor in
the product inhibition analyses which were performed with
CoASH and analog 4 as the enzyme substrates. On the HPLC
chromatograms, analog 7 was well separated from analog 1
which is the direct product for the reaction between CoASH
and substrate 4. The kcat and Km measurements were made for
CoASH (concentration range of 0.05^2.0 mM) at a ¢xed sub-
strate 4 concentration (4.0 mM) and three di¡erent ¢xed concen-
trations (0, 12, and 25 WM) of the bisubstrate analog 7, as well as
for substrate 4 (concentration range of 0.5^8.0 mM) at a ¢xed
CoASH concentration (2.0 mM) and three di¡erent ¢xed concen-
trations (0, 12, and 24 WM) of the bisubstrate analog 7. Alkyl-
transferase assays were performed as described above and in [24].
A concentration range of 0.5^1.0 WM of AANAT was employed.
All the data points for an individual experiment were ¢rst ¢tted
to the equations for all three inhibition patterns, i.e. linear com-
petitive (Eq. 2), linear non-competitive (Eq. 3), and linear uncom-
petitive inhibition (Eq. 4) using a non-linear least squares ap-
proach with the computer program KinetAsyst II1
(IntelliKinetics, State College, PA, USA) based on the Cleland
algorithms [44]. The Kii = Ki intercept and Kis = Ki slope. The best
¢t for a single data set was one having the smallest S.E.M. values
and the sum of the squares of the residuals :
V  V mS=Km1 I=K is  S 2
V  V mS=Km1 I=K is  S1 I=K ii 3
V  V mS=Km  S1 I=K ii 4
4.10. Rate versus pH pro¢le studies
CoASH and N-chloroacetyltryptamine (4) were employed in
the rate versus pH pro¢le analysis. The kcat and Km measure-
ments were made for CoASH (concentration range of 0.1^2.0
mM) at ¢xed substrate 4 concentration (8.0 mM), as well as for
substrate 4 (concentration range of 0.5^8.0 mM) at ¢xed CoASH
concentration (2.0 mM) in the pH range 6.0^8.2. Alkyltransferase
assays were performed as described above and in [24]. At each
pH investigated, enzyme activities were shown to be linear for at
least 4 min and standard Michaelis^Menten kinetic behavior was
observed. All assay reactions were initiated with the addition of
substrate 4. A concentration range of 0.1^3.0 WM of AANAT
was employed. The following bu¡ers were used to obtain the
desired pH values: MES for pH 6.0 and 6.4; sodium phosphate
for pH 6.8; MOPS for pH 7.4; EPPS for pH 8.2. The kcat and
kcat/Km data were ¢tted into Eqs. 5 and 6, respectively, where H is
the proton concentration, and K1 is the dissociation constant for
an ionizable group from enzyme or substrate that facilitates the
reaction in its deprotonated form [41]:
logkcatapp  logkcat=1H=K1 5
logkcat=Kmapp  logkcat=Km=1H=K1 6
4.11. AANAT acetyltransferase inhibition studies of
N-haloacetyltryptamines
Acetyltransferase activity was measured as described previously
using a spectrophotometric assay in which CoASH levels were
determined indirectly by monitoring its reaction product with
DTNB at 412 nm [18]. Assay reactions (pH 6.8) containing ace-
tyl-CoASH (1.0 mM), tryptamine (1.0 mM), and N-haloacetyl-
tryptamines (varied around IC50) were initiated with AANAT
and the reactions were allowed to proceed for 2 or 4 min at
30‡C before quenching with a 3.2 M aqueous guanidinium hydro-
chloride solution (pH 6.8). Rate measurements were made under
initial conditions, i.e. limiting substrate turnover 9 10%. All mea-
surements were made in duplicate and data agreed within 20% in
each duplicate run. A background (quenched before adding AA-
NAT) was run for each inhibitor concentration. From non-linear
plots of rate versus inhibitor concentration, an IC50 was obtained
for each inhibitor as an indicator of the potency (Table 2).
4.12. Pineal cell culture AANAT inhibition studies
N-Chloroacetyltryptamine (4) was studied for its in vivo inhib-
itory e¡ects on AANAT acetyltransferase activity and melatonin
levels. Assays were conducted essentially as described previously
[24]. Data are shown in Table 3.
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